Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
The American Journal of Cardiology|September 10, 2014
A kinetic model for the integrated assessment of safety and efficacy in clinical trialsGeorge A DiamondCurrent Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
ApoA-I Milano/phospholipid complexes emerging pharmacological strategies and medications for the prevention of atherosclerotic plaque progressionSanjay Kaul, Prediman K ShahJournal of the American College of Cardiology|June 11, 2013
The ATLAS ACS 2-TIMI 51 trial and the burden of missing data: (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51)Mori J Krantz, Sanjay KaulCirculation|November 16, 2020
Benefit-Risk Tradeoffs in Assessment of New Drugs and DevicesSanjay Kaul, Norman Stockbridge, Javed ButlerThrombosis and Haemostasis|August 31, 2020
Lessons Learnt from Recent Trials in Ischemic Heart DiseaseJohn M Mandrola, Sanjay Kaul, Andrew FoyHeart (British Cardiac Society)|November 14, 2009
Advances in antiplatelet treatment for acute coronary syndromesShervin Eshaghian, Prediman K Shah, Sanjay KaulReviews in Cardiovascular Medicine|January 15, 2008
Cardiac amyloidosis: new insights into diagnosis and managementShervin Eshaghian, Sanjay Kaul, Prediman K ShahPlos One|October 21, 2015
Dietary Intervention for Overweight and Obese Adults: Comparison of Low-Carbohydrate and Low-Fat Diets. A Meta-AnalysisJonathan Sackner-Bernstein, David Kanter, Sanjay KaulJournal of the American College of Cardiology|November 26, 2016
Troponin Testing for CliniciansJohn E Brush, Sanjay Kaul, Harlan M KrumholzJournal of the American College of Cardiology|September 5, 2006
Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validatedSanjay Kaul, Andrew A Zadeh, Prediman K ShahPageof 10